177,263 research outputs found
Flexible Measures in Magnetic Active Shielding
No full textBrowse Conference Publications > Electromagnetic Field Computa ...
Flexible measures in magnetic Active Shielding .This paper appears in:
Electromagnetic Field Computation (CEFC), 2010 14th Biennial IEEE Conference on
Date of Conference: 9-12 May 2010
Author(s): Formisano, A.
Dip. Ing. dell'Inf., Seconda Univ. di Napoli, Aversa, Italy
Lupoli, M.C. ; Martone, R.
Page(s): 1
Product Type: Conference Publications
5481633 searchabstract .Abstract
The reduction in protected regions of low frequency magnetic fields is a complex problem when the sources are not known. The paper proposes a procedure able to choose the best currents able to mitigate the disturbance field. The magnetic field is represented by suitable series of eigenfunctions in the domain of interest. The procedure includes a field identification step starting from a set of measurements and a current design step, possibly based on a preliminary design of specialized shimming coils sets
Quality of life in overweight (obese) and normal-weight women with polycystic ovary syndrome
No full textAnnalisa Panico,1 Giovanni Messina,2,3 Gelsy Arianna Lupoli,1 Roberta Lupoli,1 Marianna Cacciapuoti,1 Fiorenzo Moscatelli,2 Teresa Esposito,3 Ines Villano,3 Anna Valenzano,2 Vincenzo Monda,3 Antonietta Messina,3 Francesco Precenzano,4 Giuseppe Cibelli,2 Marcellino Monda,3 Giovanni Lupoli1 1Department of Clinical Medicine and Surgery, University of Napoli Federico II, Naples, Italy; 2Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy; 3Department of Experimental Medicine, Second University of Naples, Naples, Italy; 4Department of Mental and Physical Health, and Preventive Medicine, Child and Adolescent Neuropsychiatry Unit, Second University of Naples, Naples, Italy Objective: Polycystic ovary syndrome (PCOS) is characterized by phenotypic heterogeneity and has a wide variety of consequences. Approximately half of women with PCOS are overweight or obese, and their obesity may be a contributing factor to PCOS pathogenesis through different mechanisms. The aim of this study was to evaluate if PCOS alone affects the patients’ quality of life and to what extent obesity contributes to worsen this disease. Design: To evaluate the impact of PCOS on health-related quality-of-life (HRQoL), 100 Mediterranean women with PCOS (group A), 50 with a body mass index (BMI) >25 kg/m2 (group A1) and 50 with BMI <25 kg/m2 (group A2), were recruited. They were evaluated with a specific combination of standardized psychometric questionnaires: the Symptom Checklist-90 Revised, the 36-Item Short-Form Health Survey, and the Polycystic Ovary Syndrome Questionnaire. The patients were compared with a normal-weight healthy control group of 40 subjects (group B). Another control group of 40 obese healthy women (group C) was used to make a comparison with PCOS obese patients (A1). Results: Our results showed a considerable worsening of HRQoL in PCOS patients (A) compared with controls (B). In addition, patients with PCOS and BMI >25 (A1) showed a significant and more marked reduction in scores, suggesting a lower quality of life, compared with controls (B) and with normal-weight PCOS patients (A2). Conclusion: PCOS is a complex disease that alone determines a deterioration of HRQoL. The innovative use of these psychometric questionnaires in this study, in particular the PCOS questionnaire, has highlighted that obesity has a negative effect on HRQoL. It follows that a weight decrease is associated to phenotypic spectrum improvement and relative decrement in psychological distress. Keywords: polycystic ovary syndrome, obesity, normal-weight, health-related quality-of-life, psychological disturbance
'Humanus animus nusquam consistit': Doctor Sanchez's Diagnosis of the Incurable Human Unrest and Ignorance
No full textDei «quattro scettici rinascimentali» Sanchez rappresenta l’autore in cui la indagine epistemologica raggiunge la forma più radicale e sistematica. Un’indagine accurata della sua opera filosofica mette in evidenza l’ingiustificata sottovalutazione storica delle sue dottrine e l’essenziale ruolo da esse svolto nella delineazione della peculiare impostazione del problema epistemologico che è alla base dell’ideismo del XVII secolo sia nella forma cartesiana, sia in quella lockiana
Postprandial glucose control in type 1 diabetes:importance of the gastric emptying rate
No full textThe achievement of optimal post-prandial (PP) glucose control in patients with type diabetes (T1DM) remains a great challenge. This review summarizes the main factors contributing to PP glucose response and discussesthe likely reasons why PP glucose control is rarely achieved in T1DM patients. The macronutrient composition of the meal, the rate of gastric emptyingand premeal insulin administration are key factors affecting the PP glucoseresponse in T1DM. Although the use of continuous insulin infusion systems has improved PP glucose control compared to conventional insulin therapy, there is still need for further ameliorations. T1DM patients frequently present a delayed gastric emptying (GE) that produces a lower but more prolongedPP hyperglycemia.In addition, delayed GE is associated with a longer time to reach the glycemic peak, with a consequent mismatch between PP glucose elevation and the timing of premeal insulin action. On this basis, including GE time and meal composition in the algorithms for insulin bolus calculation of the insulin delivery systems could be an important step forward for optimization of PP glucose control in T1DM
Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study
No full textBACKGROUND - : Antithrombin deficiency, defined by antithrombin levels of 80%) and were followed up for a mean of 8.70 years to assess the incidence of VTE recurrence. A total of 823 patients (mean age, 48.3 years; 41.9% male) were enrolled. Recurrent VTE occurred in 253 patients (3.53% per patient-year). With stratification for antithrombin levels, VTE recurrence occurred in 19 patients with antithrombin levels 80% (3.31% per patient-year). After adjustment for major VTE risk factors and for anticoagulation duration, the risk of VTE recurrence was significantly higher in patients with antithrombin levels 80%. When the population was stratified according to the presence or absence of major risk factors for the index event, the association remained significant only in patients with unprovoked VTE. CONCLUSIONS - : The presence of mild antithrombin deficiency (70-80% antithrombin) in patients with unprovoked VTE is associated with a significantly increased risk of recurrence and should be taken into account when the duration of secondary prevention is determined
Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate.
No full textBACKGROUND:
Many reports of the effect of exogenous thyroxine therapy on bone mineral density (BMD) show a relationship between excess thyroid hormone administration and osteoporosis. The aim of this study was to evaluate the effect of antibone resorptive agents, in particular alendronate (ALN) on BMD in postmenopausal osteoporotic women with thyroid carcinoma who were receiving long-term thyrotropin (TSH)-suppressive therapy with thyroxine.
METHODS:
Seventy-four postmenopausal women with low BMD (T-score or =0.05 and < or =0.1 microU/mL) for about 3-9 years were selected for the study. The patients were divided into three groups according to the length of levothyroxine (LT(4)) treatment prior to the beginning of the study: group A (TSH-suppressive therapy for about 3 years), group B (for about 6 years), and group C (for about 9 years). These patients were compared with 74 matched women not taking LT(4). All patients and controls were treated with bisphosphonates, calcium, and vitamin D for 2 years and evaluated.
RESULTS:
After 24 months of treatment group A showed a 7.8% increase in lumbar BMD; group B, a 4.6% increase; and group C, a 0.86% increase. In the control group BMD increased 8.2%. A significant difference was found in both lumbar and femoral BMD increase among the three groups: group C had a lower BMD increase than group A (p < 0.001) and B (p < 0.001).
CONCLUSIONS:
In postmenopausal women who were receiving adequate amounts of calcium and vitamin D in their diet ALN was less effective for those who were also receiving TSH-suppressive doses of LT(4) for either 6 or 9 years. The positive effect of ALN on BMD was less for longer periods of LT(4) treatment. It seems likely that other bisphosphonates would also be less effective in increasing BMD in postmenopausal women receiving TSH-suppressing doses of LT(4)
Influence of body surface area on serum peak thyrotropin (TSH) levels after recombinant human TSH administration
No full textRecombinant human TSH (rhTSH) has been proposed as an alternative method to the withdrawal of thyroid hormones in the follow-up of differentiated thyroid cancer. The aim of the present study was to evaluate the influence of several demographic and anthropometric parameters [age, body weight, height, body mass index, and body surface area (BSA)] on serum peak TSH levels after rhTSH administration. rhTSH was administered to 112 patients with differentiated thyroid carcinoma according to the conventional two-dose schedule (0.9 mg/d). Serum TSH levels were measured 24 h before and after the first administration of rhTSH, and then 24, 48, and 72 h after the second administration of rhTSH. In one severely obese patient, serum peak TSH values did not reach a valid stimulation range. Serum peak TSH levels were negatively related to body weight (r = -0.69; P < 0.0001), body mass index (r = -0.51; P < 0.0001), and BSA (r = -0.72; P < 0.0001). In a multivariate regression analysis including demographic and anthropometric variables, only BSA was independently associated to serum peak TSH concentrations (standardized β coefficient = -0.721; P < 0.0001). In conclusion, body size seems to influence serum peak TSH levels after rhTSH administration. Future studies should evaluate the possibility of using personalized rhTSH doses, adjusted in relation to BSA
Podisus aenescens
No full text<i>Podisus aenescens</i> (Stål, 1860) <p>(Fig. 2C)</p> <p> <b>Examined material</b> (n: 69). FRENCH GUIANA.— No locality mentioned, ϐ 1899 Oberthür coll. Bar (coll. MNHN).— <b>Kourou</b>, les Roches de Kourou, ϐ 1907 E. Le Moult <i>leg.</i> (coll. MNHN).— <b>Mana</b>, Laussat Ouest, FIT, ♀ 18.X.2010, G. Lamarre <i>leg</i>. (coll. RL).— <b>Régina</b>, Nouragues, Saut Pararé, FIT, ϐ 5. VI.2010, SEAG <i>leg</i>. (coll. RL).— <b>Roura</b>, downtown, hand catching, ♀ 28.IV.2002, R. Lupoli <i>leg</i>.; Auberge des Orpailleurs, hand catching, ϐ 16.X.2004, S. & R. Hugel <i>leg</i>. (coll. RL); Montagne des Chevaux RN2 pK22, FIT, ϐ 24.I.2010, ♀ 29.VIII.2010, ♀ 13.XI.2010, ♀ 26.XII.2010, ϐ 30.IV.2011, ϐ 8.V.2011, ♀ 1.VII.2012, ♀ 3.I.2015, SEAG <i>leg</i>. (coll. RL).– <b>Saül</b>, Boucle des Gros Arbres, hand catching, 3♀ 2ϐ 2.IV.2000, J.C. Streito <i>leg</i>. (coll. JCS); Layon Eaux Claires 2ϐ 4.IV.2000, ϐ 6.IV.2000 J.C. Streito <i>leg</i>. (coll. JCS); Belvédère, FIT, ♀ 26.VIII.2010, ϐ 2.IX.2010, ϐ 17.XI.2010, 1ϐ 1♀ 20.XII.2010, ϐ 4.I.2011, 3♀ 11.I.2011, 3♀ 17.I.2011, 3♀ 24.I.2011, 4♀ 31.I.2011, 5♀ 7.II.2011, 7♀ 14.II.2011, ϐ 7.III.2011, ♀ 14.III.2011, ϐ 22.III.2011, ♀ 30.III.2011, 2ϐ 14.IV.2011, ϐ 21.IV.2011, 2♀ 1ϐ 28.IV.2011, ϐ 20.V.2011, ♀ 30. VI.2011, ϐ 4.VIII.2011, SEAG <i>leg</i>. (coll. RL).— <b>St-Laurent-du-Maroni</b>, St-Jean-du-Maroni, ϐ 1907 E. Le Moult <i>leg</i>. (coll. MNHN); Forêt domaniale (70m), ♀ 1.II.2004, J.C. Streito <i>leg</i>. (coll. JCS) — <b>Sinnamary</b>, crique Parakou, hand catching, ϐ 15.IX.1998, R. Lupoli <i>leg</i>. (coll. RL).</p> <p> <b>Literature data</b>. <b>Montsinéry-Tonnegrande</b>, 23.III.1978, 23.X.1980 on rice; <b>Matoury</b>, 7. VI.1980; Nancibo 12.II.1981 identified as <i>Podisus</i> sp. (Remillet, 1988).— French Guiana, but no locality mentioned (Thomas, 1992).</p> <p> <b>Distribution</b>. Argentina, Bolivia, Brazil, Colombia, Costa Rica, Guatemala, Ecuador, French Guiana, Leeward Island, Mexico, Panama, Paraguay, Peru.</p> <p> <b>Comments</b>. This species does not seem to be attracted by lights since it was mainly collected with FIT and by hand catching.</p>Published as part of <i>Lupoli, Roland, 2019, First catalogue of the Asopinae (Hemiptera, Pentatomidae) from French Guiana, pp. 76-88 in Zootaxa 4668 (1)</i> on pages 80-81, DOI: 10.11646/zootaxa.4668.1.4, <a href="http://zenodo.org/record/3448993">http://zenodo.org/record/3448993</a>
Oplomus salamandra
No full textOplomus salamandra (Burmeister, 1835) (Fig. 2B) Examined material (n: 14). FRENCH GUIANA.— No locality mentioned, 5♀ 2ϐ 1899 Oberthür coll. Bar (coll. MNHN), identified as Oplomus tripustulatus by Schouteden.— Kourou, ϐ XI.1914, R. Benoist leg. (coll. MNHN).— Saül, Boucle des Gros Arbres, hand catching, ♀ 3.IV.2000, ϐ 5.IV.2000, 3ϐ 6.IV.2000, J.C. Streito leg. (coll. JCS).— Maripasoula, Massif du Mitaraka, UV-MV light trap, ϐ 12.VIII.2015, La Planète Revisitée—MNHN/PNI Guyane 2015 (APA 973-1) MNHN leg. (coll. RL). Distribution. Argentina, Bolivia, Colombia, Ecuador, French Guiana, Peru, Surinam, Venezuela. Comments. New record of this species in French Guiana.Published as part of Lupoli, Roland, 2019, First catalogue of the Asopinae (Hemiptera, Pentatomidae) from French Guiana, pp. 76-88 in Zootaxa 4668 (1) on page 80, DOI: 10.11646/zootaxa.4668.1.4, http://zenodo.org/record/344899
- …
